Quality

Trusted Quality and Compliance

Your patients’ safety is paramount and non-negotiable, so quality is at the forefront of our CDMO approach. We strive to maintain excellence in our quality systems and manufacturing, and are committed to continuous improvement.

Adhering to a globally-integrated and comprehensive quality management system, our cGMP facilities are fully compliant with current regulatory requirements and applicable standards, while undergoing frequent regulatory inspections and customer audits.

Market Agency	EMA, EU local	FDA	NMPA	PMDA	ANVISA	Health Canada
Bergamo, Italy
Caponago, Italy
Chenôve, France
Colorado (Boulder), US
Ettingen, Switzerland
Frankfurt, Germany
Fribourg, Switzerland
Liestal, Switzerland
Lisbon, Portugal
Plankstadt, Germany
Shanghai, China
South Carolina (North Augusta), US

Speed to Market
Quality and Compliance
Flexibility and Transparency

Speed to Market

In pharmaceutical development money is time, and time is of the essence. We understand the urgency of producing critical medicines, and are here to support the management of your supply chain timelines, regardless of the development phase. Our expert teams have decades of experience using cutting-edge technologies across our integrated facility network to help bring your complex modalities to market quickly.

Quality and Compliance

Quality is the most important ingredient for therapeutic effectiveness, and thus, commercial success. Our commitment to seek the highest standards of quality and compliance is at the core of CordenPharma. By continuing to invest heavily in ongoing compliance programs with budgeted investments in improvements such as compliance-enhancing IT solutions, we make no compromises in this area. Our objective is to not only meet, but surpass applicable regulatory requirements and legislation to provide services that elevate and ensure product integrity for you and the patients you serve.

Flexibility and Transparency

Navigating through your drug development life-cycle can present challenges. CordenPharma understands that a successful CDMO / pharma innovator partnership requires regular touch-points of insight, feedback and alignment along the way. With this in mind, we have made a collaborative commitment across the entire organization, from executive leadership and project management teams to facility operators, to react with flexibility and transparency to your changing needs and strive every day to steer your project towards our common goal: the health and well being of your patients.